Hims & Hers Health Net Income 2020-2023 | HIMS
Hims & Hers Health Annual Net Income (Millions of US $) |
|
---|---|
2023 | $-24 |
2022 | $-66 |
2021 | $-108 |
2020 | $-18 |
2019 | $-72 |
2018 | $ |
Hims & Hers Health Quarterly Net Income (Millions of US $) |
|
---|---|
2023-12-31 | $1 |
2023-09-30 | $-8 |
2023-06-30 | $-7 |
2023-03-31 | $-10 |
2022-12-31 | $-11 |
2022-09-30 | $-19 |
2022-06-30 | $-20 |
2022-03-31 | $-16 |
2021-12-31 | $-31 |
2021-09-30 | $-16 |
2021-06-30 | $-9 |
2021-03-31 | $-51 |
2020-12-31 | $-5 |
2020-09-30 | $-6 |
2020-06-30 | $-1 |
2020-03-31 | $-6 |
2019-12-31 | |
2019-09-30 | $0 |
2019-06-30 | $-0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.629B | $0.872B |
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
Axonics (AXNX) | United States | $3.394B | 0.00 |
10x Genomics (TXG) | United States | $3.206B | 0.00 |
Enovis (ENOV) | United States | $3.022B | 22.96 |
Azenta (AZTA) | United States | $2.872B | 234.09 |
Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
Privia Health (PRVA) | United States | $2.135B | 94.68 |
Schrodinger (SDGR) | United States | $1.688B | 0.00 |
Omnicell (OMCL) | United States | $1.246B | 30.48 |
Phreesia (PHR) | United States | $1.154B | 0.00 |
Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
Standard BioTools (LAB) | United States | $0.685B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
Talkspace (TALK) | United States | $0.520B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
Pulmonx (LUNG) | United States | $0.281B | 0.00 |
American Well (AMWL) | United States | $0.156B | 0.00 |
P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
Augmedix (AUGX) | United States | $0.136B | 0.00 |
MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
Outset Medical (OM) | United States | $0.123B | 0.00 |
TruBridge (TBRG) | United States | $0.115B | 4.91 |
111 (YI) | China | $0.084B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Movano (MOVE) | United States | $0.027B | 0.00 |
Cue Health (HLTH) | United States | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Centogene (CNTG) | Germany | $0.013B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.007B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |